These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 35343940)
1. Highlights in graft-vs-host disease from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary. Chen YB Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 3(1):17-23. PubMed ID: 35343940 [No Abstract] [Full Text] [Related]
2. Highlights in graft-vs-host disease from the 63rd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 3(1):1-24. PubMed ID: 35343939 [No Abstract] [Full Text] [Related]
3. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary. Winter A Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):14-18. PubMed ID: 35343942 [No Abstract] [Full Text] [Related]
4. Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary. Mato A Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 2(1):17-19. PubMed ID: 35343936 [No Abstract] [Full Text] [Related]
5. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary. Goy AH Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):18-23. PubMed ID: 35343947 [No Abstract] [Full Text] [Related]
6. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. DiPersio JF Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914 [No Abstract] [Full Text] [Related]
7. Advances in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: commentary. Coombs CC Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):15-19. PubMed ID: 35343945 [No Abstract] [Full Text] [Related]
8. Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2022 Jan; 20 Suppl 2(1):1-20. PubMed ID: 35343935 [No Abstract] [Full Text] [Related]
9. Highlights in mantle cell lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 6(2):1-24. PubMed ID: 35343946 [No Abstract] [Full Text] [Related]
10. Highlights in graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):1-24. PubMed ID: 33843913 [No Abstract] [Full Text] [Related]
11. Highlights in leukemia and lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 7(2):1-20. PubMed ID: 35343944 [No Abstract] [Full Text] [Related]
12. Highlights in Hodgkin lymphoma from the 63rd American Society of Hematology Annual Meeting and Exposition. Clin Adv Hematol Oncol; 2022 Feb; 20 Suppl 5(2):1-20. PubMed ID: 35343941 [No Abstract] [Full Text] [Related]
13. Highlights in Graft-vs-Host Disease From the 60th American Society of Hematology Annual Meeting: Commentary. Jagasia M Clin Adv Hematol Oncol; 2019 Mar; 17 Suppl 6(3):16-18. PubMed ID: 31730585 [No Abstract] [Full Text] [Related]
14. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Evens AM Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922 [No Abstract] [Full Text] [Related]
15. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Garcia-Manero G Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866 [No Abstract] [Full Text] [Related]
16. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Jacobson CA Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918 [No Abstract] [Full Text] [Related]
17. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Barr PM Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916 [No Abstract] [Full Text] [Related]
18. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary. Awan FT Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856 [No Abstract] [Full Text] [Related]
19. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Salles G Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858 [No Abstract] [Full Text] [Related]
20. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary. Davids MS Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888 [No Abstract] [Full Text] [Related] [Next] [New Search]